Technology
Health
Medical

Cytosorbents

594

$6.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.92 (-12.03%) Today
+$0.08 (+1.19%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Cytosorbents and other stocks, options, ETFs, and crypto commission-free!

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. Read More The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

CEO
Phillip P. Chan
Employees
153
Headquarters
Monmouth Junction, New Jersey
Founded
2002
Market Cap
235.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.46M
High Today
$7.54
Low Today
$6.21
Open Price
$7.41
Volume
1.52M
52 Week High
$8.10
52 Week Low
$3.49

Collections

Technology
Health
Medical
Research And Development
US
North America

CTSO News

BenzingaMar 31

CytoSorb® Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care

MONMOUTH JUNCTION, N.J., March 31, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO) a critical care immunotherapy leader commercializing its CytoSorb
47

CTSO Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, After Hours

People Also Bought

Aurora Cannabis

870,118

$0.8096

-2.84%

Aurora Cannabis

870,118

$0.8096

-2.84%

Verastem

16,620

$2.52

-2.70%

Cronos Group

200,725

$5.49

+1.31%

You May Also Like

VRNT
NAT
HYLV
GSAT
CCLP
WTER
NVRO
DIFTY
PRK
ITT
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CTSO

Market Price$6.81
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Cytosorbents stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up